2m 2m 2m 2m 2m 2m 2m
ACRIVON THERAPE (ACRV)
NASDAQ
$1.99+$0.01 (+0.51%)
Price as of Jul 13, 2026 5:17 PM EDT- $84.7MMarket Cap
- 48.87%1-Year Change
- BiotechnologyIndustry
ACRIVON THERAPE (ACRV)
$1.99+$0.01 (+0.51%)
ACRV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.98 | ||
Change | +$0.02 (+1.02%) | ||
Open | $1.90 | ||
High | $2.11 | ||
Low | $1.90 | ||
Previous Close | $1.96 | ||
Volume | 1,105,688 | ||
30-Day Average Volume | 475,269 | ||
1-Week Change | 11.24% | ||
1-Month Change | 33.78% | ||
1-Year Change | 48.87% | ||
3-Year Change | -83.82% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 42.8M | ||
Total Assets | $107.8M | ||
Market Cap | $84.7M | ||
Enterprise Value | $50.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$19.0M | ||
Free Cash Flow | -$20.6M | ||
EBIT | -$19.0M | ||
EBITDA | -$18.7M | ||
Net Working Capital | $88.2M | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -18 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue